Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
| Author | |
|---|---|
| Abstract |
:
Cardiomyocyte hypertrophy is a hallmark of cardiac dysfunction in patients with aortic stenosis (AS), and can be triggered by left ventricular (LV) pressure overload in mice by aortic banding (AB). Syndecan-4 is a transmembrane heparan sulphate proteoglycan which is found increased in the myocardium of AS patients and AB mice. The role of syndecan-4 in cardiomyocyte hypertrophy is not well understood. |
| Year of Publication |
:
2022
|
| Journal |
:
Molecular biology reports
|
| Date Published |
:
2022
|
| ISSN Number |
:
0301-4851
|
| URL |
:
https://doi.org/10.1007/s11033-022-07985-y
|
| DOI |
:
10.1007/s11033-022-07985-y
|
| Short Title |
:
Mol Biol Rep
|
| Download citation |
